Proarrhythmic effects of flecainide. Experimental evidence for increased susceptibility to reentrant arrhythmias

scientific article published on 01 October 1991

Proarrhythmic effects of flecainide. Experimental evidence for increased susceptibility to reentrant arrhythmias is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1161/01.CIR.84.4.1808
P698PubMed publication ID1914116

P50authorJosep BrugadaQ1706299
P2093author name stringC Kirchhof
M Allessie
L Boersma
P433issue4
P407language of work or nameEnglishQ1860
P304page(s)1808-1818
P577publication date1991-10-01
P1433published inCirculationQ578091
P1476titleProarrhythmic effects of flecainide. Experimental evidence for increased susceptibility to reentrant arrhythmias
P478volume84

Reverse relations

cites work (P2860)
Q38566757Arrhythmogenicity of antiarrhythmic drugs and intraventricular conduction disorders: possible aggravation by myocardial ischemia--study in the porcine in situ heart
Q51661074Clinical evaluation of the use-dependent QRS prolongation and the reverse use-dependent QT prolongation of class I and class III antiarrhythmic agents and their value in predicting efficacy.
Q35870956Effects of hyperkalaemia on the depression of maximum rate of depolarization by class I antiarrhythmic agents in guinea-pig myocardium
Q51515949Effects of lidocaine and mexiletine on defibrillation energy requirements in animals treated with flecainide.
Q51542060Electrophysiologic effects of sodium channel blockade on anisotropic conduction and conduction block in canine myocardium: preferential slowing of longitudinal conduction by flecainide versus disopyramide or lidocaine.
Q41910718Flecainide exerts paradoxical effects on sodium currents and atrial arrhythmia in murine RyR2-P2328S hearts.
Q54464188Flecainide-induced Increase in QRS Duration and Proarrhythmia during Exercise.
Q39297241Management of life-threatening flecainide overdose: A case report and review of the literature
Q44419147Pharmacodynamic Equivalence of Two Flecainide Acetate Formulations in Patients With Paroxysmal Atrial Fibrillation by QRS Analysis of Ambulatory Electrocardiogram
Q41612488Poisoning by sodium channel blocking agents
Q33812750Predicting drug-induced slowing of conduction and pro-arrhythmia: identifying the 'bad' sodium current blockers
Q37073199QT interval prolongation and torsade de pointes: Synergistic effect of flecainide and H1 receptor antagonists.
Q44413384Safety of a controlled-release flecainide acetate formulation in the prevention of paroxysmal atrial fibrillation in outpatients
Q35236285Subclassification of class I antiarrhythmic drugs: enhanced relevance after CAST
Q40485982The Complexity of Mechanisms in Ventricular Tachycardia
Q58716724Time-dependent antiarrhythmic effects of flecainide on induced atrial fibrillation in horses

Search more.